Icu Medical (ICUI) Research & Development (2009 - 2026)

Icu Medical's Research & Development history runs 18 years deep, the most recent figure standing at $21.3 million for Q1 2026.

• Quarterly Research & Development fell 8.63% year-over-year to $21.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $85.5 million (down 5.09% YoY) and the FY2025 annual result came in at $87.5 million, down 1.26% from the prior year.
• Research & Development was $21.3 million for Q1 2026 at Icu Medical, up from $21.1 million in the prior quarter.
• Across five years, Research & Development topped out at $23.9 million in Q1 2022 and bottomed at $19.8 million in Q1 2023.
• A 5-year average of $22.1 million and a median of $22.3 million in 2023 frame the typical range for Research & Development.
• Annual changes were most pronounced in 2022 — Research & Development jumped 122.91% — and 2023, when it dropped 17.22%.
• Icu Medical's Research & Development stood at $23.4 million in 2022, then slipped by 4.41% to $22.4 million in 2023, then fell by 0.25% to $22.4 million in 2024, then slipped by 5.68% to $21.1 million in 2025, then rose by 0.92% to $21.3 million in 2026.
• Business Quant data shows ICUI's Research & Development at $21.3 million in Q1 2026, $21.1 million in Q4 2025, and $21.3 million in Q3 2025.